446 related articles for article (PubMed ID: 23437062)
1. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.
Song MA; Tiirikainen M; Kwee S; Okimoto G; Yu H; Wong LL
PLoS One; 2013; 8(2):e55761. PubMed ID: 23437062
[TBL] [Abstract][Full Text] [Related]
2. Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral status.
Song MA; Kwee SA; Tiirikainen M; Hernandez BY; Okimoto G; Tsai NC; Wong LL; Yu H
Epigenetics; 2016 Jun; 11(6):464-74. PubMed ID: 27248055
[TBL] [Abstract][Full Text] [Related]
3. Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips.
Shen J; Wang S; Zhang YJ; Wu HC; Kibriya MG; Jasmine F; Ahsan H; Wu DP; Siegel AB; Remotti H; Santella RM
Epigenetics; 2013 Jan; 8(1):34-43. PubMed ID: 23208076
[TBL] [Abstract][Full Text] [Related]
4. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
[TBL] [Abstract][Full Text] [Related]
5. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
[TBL] [Abstract][Full Text] [Related]
6. Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma.
Jain S; Chen S; Chang KC; Lin YJ; Hu CT; Boldbaatar B; Hamilton JP; Lin SY; Chang TT; Chen SH; Song W; Meltzer SJ; Block TM; Su YH
PLoS One; 2012; 7(4):e35789. PubMed ID: 22536438
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide profiling of DNA methylation and tumor progression in human hepatocellular carcinoma.
Nishida N; Nishimura T; Nakai T; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Inoue T; Minami Y; Ueshima K; Sakurai T; Kudo M
Dig Dis; 2014; 32(6):658-63. PubMed ID: 25376281
[TBL] [Abstract][Full Text] [Related]
8. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
[TBL] [Abstract][Full Text] [Related]
9. The landscape of DNA methylation in hepatocellular carcinoma.
Zheng YF; Lu X; Zhang XY; Guan BG
J Cell Physiol; 2019 Mar; 234(3):2631-2638. PubMed ID: 30145793
[TBL] [Abstract][Full Text] [Related]
10. Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma.
Ammerpohl O; Pratschke J; Schafmayer C; Haake A; Faber W; von Kampen O; Brosch M; Sipos B; von Schönfels W; Balschun K; Röcken C; Arlt A; Schniewind B; Grauholm J; Kalthoff H; Neuhaus P; Stickel F; Schreiber S; Becker T; Siebert R; Hampe J
Int J Cancer; 2012 Mar; 130(6):1319-28. PubMed ID: 21500188
[TBL] [Abstract][Full Text] [Related]
11. Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis.
Mah WC; Thurnherr T; Chow PK; Chung AY; Ooi LL; Toh HC; Teh BT; Saunthararajah Y; Lee CG
PLoS One; 2014; 9(8):e104158. PubMed ID: 25093504
[TBL] [Abstract][Full Text] [Related]
12. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel methylation markers in hepatocellular carcinoma using a methylation array.
Shin SH; Kim BH; Jang JJ; Suh KS; Kang GH
J Korean Med Sci; 2010 Aug; 25(8):1152-9. PubMed ID: 20676325
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
Wang Y; Liu D; Jin X; Song H; Lou G
Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
[TBL] [Abstract][Full Text] [Related]
16. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
Matsushita J; Suzuki T; Okamura K; Ichihara G; Nohara K
Environ Health Prev Med; 2020 Jul; 25(1):31. PubMed ID: 32703154
[TBL] [Abstract][Full Text] [Related]
17. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma.
Jung N; Won JK; Kim BH; Suh KS; Jang JJ; Kang GH
J Korean Med Sci; 2012 Jun; 27(6):594-604. PubMed ID: 22690089
[TBL] [Abstract][Full Text] [Related]
19. [Detection of aberrant promoter CpG islands hypermethylation of GSTP1 in human primary hepatocellular carcinomas].
Wang JH; Qin Y; Li B; Sun ZL; Sun ZF; Guan QL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):686-8. PubMed ID: 16235538
[TBL] [Abstract][Full Text] [Related]
20. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
